Medigen Vaccine Biologics (ROCO:6547) FCF Margin % : 130.66% (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Medigen Vaccine Biologics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Medigen Vaccine Biologics's Free Cash Flow for the three months ended in Dec. 2024 was NT$168.3 Mil. Medigen Vaccine Biologics's Revenue for the three months ended in Dec. 2024 was NT$128.8 Mil. Therefore, Medigen Vaccine Biologics's FCF Margin % for the quarter that ended in Dec. 2024 was 130.66%.

As of today, Medigen Vaccine Biologics's current FCF Yield % is 0.04%.

The historical rank and industry rank for Medigen Vaccine Biologics's FCF Margin % or its related term are showing as below:

ROCO:6547' s FCF Margin % Range Over the Past 10 Years
Min: -51787.77 Med: -252.66 Max: 13.56
Current: 0.95

During the past 13 years, the highest FCF Margin % of Medigen Vaccine Biologics was 13.56%. The lowest was -51787.77%. And the median was -252.66%.

ROCO:6547's FCF Margin % is ranked better than
78.78% of 999 companies
in the Biotechnology industry
Industry Median: -120.3 vs ROCO:6547: 0.95

Medigen Vaccine Biologics FCF Margin % Historical Data

The historical data trend for Medigen Vaccine Biologics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigen Vaccine Biologics FCF Margin % Chart

Medigen Vaccine Biologics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

-6,042.15

13.56

-370.96

-134.36

0.95

Medigen Vaccine Biologics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial															28.34	-6.20	-86.86	-2.75	130.66

Competitive Comparison of Medigen Vaccine Biologics's FCF Margin %

For the Biotechnology subindustry, Medigen Vaccine Biologics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medigen Vaccine Biologics's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigen Vaccine Biologics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Medigen Vaccine Biologics's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Medigen Vaccine Biologics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Medigen Vaccine Biologics's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	5.773	/	605.637
	=	0.95 %

Medigen Vaccine Biologics's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	168.296	/	128.805
	=	130.66 %

Medigen Vaccine Biologics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Medigen Vaccine Biologics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medigen Vaccine Biologics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigen Vaccine Biologics Corp (ROCO:6547) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 16, Neihu Road, Lane 120, Floor 7, Section 1, Neihu District, Taipei, TWN, 11493

Website

https://www.medigenvac.com

Medigen Vaccine Biologics Corp is a biopharmaceutical company focusing on developing and producing vaccines and biologics. It is engaged in developing IP-protected cell-culture technologies for vaccine manufacturing. The company develops vaccines and affordable biosimilars to prevent regional infectious diseases. The group generates revenue from manufacturing and selling a range of Covid-19 vaccines and Covid-19 test kits and provides technical services on cellular therapy product quality and cell culture tests.

Medigen Vaccine Biologics Headlines

No Headlines